See
Genome Information for Staphylococcus aureus
Low level resistance to vancomycin in Staphylococcus aureus (VISA) is a clinical hindrance because patients infected with such strains may fail antimicrobial therapy.
More...Low level resistance to vancomycin in Staphylococcus aureus (VISA) is a clinical hindrance because patients infected with such strains may fail antimicrobial therapy. Phenotypically, VISA strains present a thickening of the cell wall which may be the result of different sets of point mutations on different bacterial genes, usually accumulated during vancomycin therapy, leading to resistance. The high plasticity of bacterial genomes within a species makes it hard to determine which mutations are correlated to the resistance phenotype. We thus sought out to sequence several isolates presenting profiles of susceptibility (VSSA), heterogeneous resistance (hVISA) and homogeneous resistance (VISA) which were either clinically isolated with these phenotypes or induced to these phenotypes by serial passage in vitro.
Less...| Accession | PRJNA341777 |
| Data Type | Genome sequencing and assembly |
| Scope | Multiisolate |
| Organism | Staphylococcus aureus[Taxonomy ID: 1280] Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus; Staphylococcus aureus |
| Grants | - "Post-Doctoral Research Fellowship" (Grant ID 2013/12107-4, Sao Paulo Research Foundation - Brazil)
- "Universal 14/2014" (Grant ID 457421/2014-2, Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil)
- "Universal 14/2012" (Grant ID 485438/2012-7, Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil)
|
| Submission | Registration date: 3-Sep-2016
Universidade de Sao Paulo |
| Relevance | Medical |
Project Data:
No public data is linked to this project. Any recently released data that cites this project will be linked to it within a few days.